NCT07208071 Investigating the Utility of Augmented Reality Assistance for Ultrasound-Guided Vascular Access
| NCT ID | NCT07208071 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alabama at Birmingham |
| Condition | Vascular Access |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-01-30 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-01-30 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will investigate the benefits of augmented reality assistance on ultrasound-guided vascular access. Using the Microsoft HoloLens 2 headset, the investigators will study the benefits of augmented reality technology as a tool for improving the success rate, efficiency, and ease of access for peripheral venous catheters, peripherally inserted central venous catheters, and central venous catheters.
Eligibility Criteria
Inclusion Criteria: * Patient requiring ultrasound-guided vascular access Exclusion Criteria: * Age less than 5 years old * Need for urgent vascular access
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07208071 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, studying Vascular Access. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07208071 currently recruiting?
Yes, NCT07208071 is actively recruiting participants. Contact the research team at jdcoote@uabmc.edu for enrollment information.
Where is the NCT07208071 trial being conducted?
This trial is being conducted at Birmingham, United States.
Who is sponsoring the NCT07208071 clinical trial?
NCT07208071 is sponsored by University of Alabama at Birmingham. The trial plans to enroll 50 participants.